Urgent Need for Early Diagnosis of Primary Liver Cancer: Glypican-3 is a Promising Candidate Biomarker

ISSN： 1176-3469

Source： Pharmaceutical & Diagnostic Innovation, Vol.3, Iss.4, 2005-04, pp. : 7-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chinese consensus on early diagnosis of primary lung cancer (2014 version)

By HuJie QianGui-Sheng BaiChun-Xue for the Lung Cancer Study Group of the Chinese Thoracic Society and the Chinese Alliance Against Lung Cancer Expert Groupcncr29571-cr-0004

Cancer, Vol. 121, Iss. 17, 2015-09 ,pp. : 3157-3164

Blackwell Publishing

Access to resources Recommend Favorite

Role of a serum-based biomarker panel in the early diagnosis of lung cancer for a cohort of high-risk patients

By YangDa-Wei ZhangYong HongQun-Ying HuJie LiChun PanBai-Shen WangQun DingFei-Hong OuJia-Xian LiuFang-Lei ZhangDan ZhouJie-Bai SongYuan-Lin BaiChun-Xue

Cancer, Vol. 121, Iss. 17, 2015-09 ,pp. : 3113-3121

Blackwell Publishing

Access to resources Recommend Favorite

Validation and Development of N-glycan as Biomarker in Cancer Diagnosis

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 11, Iss. 1, 2013-03 ,pp. : 53-58

Bentham Science Publishers

Access to resources Recommend Favorite

Early Diagnosis of Oral Cancer

By Baykul T Yilmaz HH Aydin Ü Aydin MA Aksoy MÇ Yildirim D

The Journal of International Medical Research, Vol. 38, Iss. 3, 2010-06 ,pp. : 737-749

Field House Publishing

Access to resources Recommend Favorite

Prognostic significance of long noncoding RNA Z38 as a candidate biomarker in breast cancer

Journal Of Clinical Laboratory Analysis (Electronic), Vol. 32, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite